Using omega-3 fatty acids to help pregnant smokers reduce risks to their babies
Investigating N-3 Fatty Acids to prevent Neonatal Tobacco-related outcomeS (INFANTS)
This study is looking at whether taking omega-3 fatty acids can help pregnant women who smoke reduce risks like preterm birth and complications for their babies, and it’s designed to find out if this supplement really makes a difference compared to a placebo.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10677798 on NIH RePORTER |
What this research studies
This research investigates the potential of omega-3 fatty acids to mitigate the adverse effects of smoking during pregnancy. It focuses on pregnant women who smoke, aiming to determine if supplementation with omega-3 fatty acids can reduce complications such as preterm birth and neonatal death. The study employs a double-blind methodology to ensure unbiased results, comparing outcomes between those receiving the supplement and those receiving a placebo. By addressing the nutritional deficiencies linked to smoking, this research seeks to provide a safe intervention for pregnant smokers.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant women who smoke and are seeking to reduce the risks associated with tobacco use during pregnancy.
Not a fit: Patients who do not smoke or are not pregnant may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a safe and effective intervention that reduces smoking-related complications in pregnancy, improving outcomes for both mothers and infants.
How similar studies have performed: Previous studies have shown promising results with omega-3 fatty acids in reducing preterm labor risk among smokers, suggesting potential for success in this research.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Murff, Harvey J. — Vanderbilt University Medical Center
- Study coordinator: Murff, Harvey J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.